Малайзия -
английский -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
pomarza 2 (pomalidomide capsules 2mg)
dr. reddy`s laboratories malaysia sdn. bhd. - pomalidomide -
Малайзия -
английский -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
pomarza 1 (pomalidomide capsules 1mg)
dr. reddy`s laboratories malaysia sdn. bhd. - pomalidomide -
Малайзия -
английский -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
pomarza 3 (pomalidomide capsules 3mg)
dr. reddy`s laboratories malaysia sdn. bhd. - pomalidomide -
Малайзия -
английский -
NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
pomarza 4 (pomalidomide capsules 4mg)
dr. reddy`s laboratories malaysia sdn. bhd. - pomalidomide -
Европейский союз -
английский -
EMA (European Medicines Agency)
imnovid (previously pomalidomide celgene)
bristol-myers squibb pharma eeig - pomalidomide - multiple myeloma - immunosuppressants - imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.
Израиль -
английский -
Ministry of Health
imnovid 1 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 1 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Израиль -
английский -
Ministry of Health
imnovid 2 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 2 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Израиль -
английский -
Ministry of Health
imnovid 4 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 4 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide.
Израиль -
английский -
Ministry of Health
imnovid 1 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 1 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide
Израиль -
английский -
Ministry of Health
imnovid 1 mg
neopharm scientific ltd - pomalidomide - hard capsule - pomalidomide 1 mg - pomalidomide - imnovid in combination with dexamethasone is indicated in the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least two prior treatment regimens, including both lenalidomide and bortezomib, and have demonstrated disease progression on the last therapy.imnovid in combination with bortezomib and dexamethasone is indicated in the treatment of adult patients with multiple myeloma who have received at least one prior treatment regimen including lenalidomide